GSK-3117391
CAS No. 1018673-42-1
GSK-3117391 ( CHR-5154;GSK3117391;CHR5154 )
Catalog No. M10089 CAS No. 1018673-42-1
GSK-3117391 (CHR-5154) is a novel macrophage-targeted HDAC inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 177 | Get Quote |
|
10MG | 295 | Get Quote |
|
25MG | 502 | Get Quote |
|
50MG | 709 | Get Quote |
|
100MG | 1008 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameGSK-3117391
-
NoteResearch use only, not for human use.
-
Brief DescriptionGSK-3117391 (CHR-5154) is a novel macrophage-targeted HDAC inhibitor.
-
DescriptionGSK-3117391 (CHR-5154) is a novel macrophage-targeted HDAC inhibitor, has the potential to complement existing therapies in the treatment of chronic inflammatory disorders such as rheumatoid arthritis.Rheumatoid Arthritis Phase 2 Clinical
-
SynonymsCHR-5154;GSK3117391;CHR5154
-
PathwayCell Cycle/DNA Damage
-
TargetHDAC
-
RecptorHDAC
-
Research AreaInflammation/Immunology
-
IndicationRheumatoid Arthritis
Chemical Information
-
CAS Number1018673-42-1
-
Formula Weight389.50
-
Molecular FormulaC21H31N3O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(OC1CCCC1)[C@H](C2CCCCC2)NCC3=CC=C(CCC(NO)=O)N=C3
-
Chemical Namecyclopentyl (S)-2-cyclohexyl-2-((6-(3-(hydroxyamino)-3-oxopropyl)pyridin-3-yl)amino)acetate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
EDO-S101
EDO-S101 (Tinostamustine)is a fusion molecule comprising of the alkylator bendamustine and the HDAC-inhibitor vorinostat.
-
Tucidinostat
Tucidinostat (Chidamide, HBI-8000, CS055) is a novel histone deacetylase (HDAC) inhibitor.
-
Liquiritin apioside
Liquiritin Apioside is one of the main active components in Suan-Zao-Ren decoction as a treatment for insomnia.